Principal Investigator
Byron Lam
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20220475
Clinical Trial Summary
A Phase 2a, Open Label Multicenter Clinical Trial to Evaluate the Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects with Stargardt Disease (STARLIGHT).
Phase
Phase II
Funding Agency/Sponsor
Intramural
Disease
Other